NeuroOne Medical Technologies
NMTC · NASDAQ
$0.9838−$0.0162 (−1.62%)TodayMarket closed ·
Prev close $1.00
Who owns NMTC
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 42.8% of NMTC’s shares.
- Pratt Brian12.5%
- Merchant Adventure Fund LP8.0%
- Bleichroeder LP7.7%
- Vanguard Capital Management, LLC4.1%
- Next 6 largest institutions10.6%
- All other shareholders57.2%
| Holder | Shares | % of shares |
|---|---|---|
| Pratt Brian | 1.09M | 12.48% |
| Merchant Adventure Fund LP | 700.00K | 8.05% |
| Bleichroeder LP | 666.67K | 7.66% |
| Vanguard Capital Management, LLC | 352.77K | 4.05% |
| Bard Associates Inc. | 305.43K | 3.51% |
| Perkins Capital Management, Inc. | 244.66K | 2.81% |
| Rosa (David A) | 123.37K | 1.42% |
| Geode Capital Management, L.L.C. | 93.56K | 1.08% |
| Sio Capital Management, LLC | 82.77K | 0.95% |
| Renaissance Technologies LLC | 70.86K | 0.81% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 254.94K | 2.93% |
| Vanguard Extended Market Index Fund | 90.12K | 1.04% |
| Fidelity Extended Market Index Fund | 45.05K | 0.52% |
| iShares Micro-Cap ETF | 23.95K | 0.28% |
| Fidelity Total Market Index Fund | 13.91K | 0.16% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $67.00K (1 trade) and sold $31.77K (1 trade) of NMTC on the open market.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Wambeke David J. | Award | 35.00K | — |
| Johns Emily J. | Award | 12.50K | — |
| Volker Christopher | Award | 35.00K | — |
| Mertens Steve | Award | 15.00K | — |
| Christianson Mark | Award | 12.50K | — |
| Rosa David A | Award | 68.00K | — |
| Wambeke David J. | Buy | 33.33K | $67.00K |
| Christianson Mark | Sale | 10.00K | $31.77K |
Short interest
Settled Sep 30, 2026
- Shares short
- 178.73K
- Days to cover
- 1.19
- % of shares outstanding
- 2.05%
- Average daily volume
- 150.12K
- Change since last report
- +135.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.